These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 30813192)

  • 1. Low molecular weight heparin monotherapy for recurrent abortion with antiphospholipid system: A protocol of a systematic review.
    Ni L; Sun XQ; Zhao DX; Zhu ZW
    Medicine (Baltimore); 2019 Feb; 98(8):e14619. PubMed ID: 30813192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
    Hamulyák EN; Scheres LJ; Marijnen MC; Goddijn M; Middeldorp S
    Cochrane Database Syst Rev; 2020 May; 5(5):CD012852. PubMed ID: 32358837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis on aspirin combined with low-molecular-weight heparin for improving the live birth rate in patients with antiphospholipid syndrome and its correlation with d-dimer levels.
    Shi T; Gu ZD; Diao QZ
    Medicine (Baltimore); 2021 Jun; 100(25):e26264. PubMed ID: 34160390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin or heparin or both in the treatment of recurrent spontaneous abortion in women with antiphospholipid antibody syndrome: a meta-analysis of randomized controlled trials.
    Lu C; Liu Y; Jiang HL
    J Matern Fetal Neonatal Med; 2019 Apr; 32(8):1299-1311. PubMed ID: 29179589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregnancy outcomes and adverse events in patients with recurrent miscarriage receiving fondaparinux versus low molecular-weight heparin: A meta-analysis.
    Mu F; Wang M; Huang J; Wang F
    Eur J Obstet Gynecol Reprod Biol; 2023 Aug; 287():29-35. PubMed ID: 37276726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of recurrent miscarriage in women with antiphospholipid syndrome: A systematic review and network meta-analysis.
    Yang Z; Shen X; Zhou C; Wang M; Liu Y; Zhou L
    Lupus; 2021 Jan; 30(1):70-79. PubMed ID: 33081590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enoxaparin versus unfractionated heparin in the management of recurrent abortion secondary to antiphospholipid syndrome.
    Fouda UM; Sayed AM; Abdou AM; Ramadan DI; Fouda IM; Zaki MM
    Int J Gynaecol Obstet; 2011 Mar; 112(3):211-5. PubMed ID: 21251653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombotic therapy to prevent recurrent pregnancy loss in antiphospholipid syndrome-What is the evidence?
    Hamulyák EN; Scheres LJJ; Goddijn M; Middeldorp S
    J Thromb Haemost; 2021 May; 19(5):1174-1185. PubMed ID: 33687789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin for preventing adverse obstetrical outcomes in pregnant women with antiphospholipid syndrome, a systematic review and meta-analysis.
    Guerby P; Fillion A; O'Connor S; Bujold E
    J Gynecol Obstet Hum Reprod; 2021 Feb; 50(2):101974. PubMed ID: 33171281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome.
    Kaandorp S; Di Nisio M; Goddijn M; Middeldorp S
    Cochrane Database Syst Rev; 2009 Jan; (1):CD004734. PubMed ID: 19160241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregnancy morbidity in antiphospholipid syndrome: what is the impact of treatment?
    de Jesús GR; Rodrigues G; de Jesús NR; Levy RA
    Curr Rheumatol Rep; 2014 Feb; 16(2):403. PubMed ID: 24390757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical efficacy and adverse effects of LMWH combined with ASA in the treatment of RSA: A meta-analysis and systematic review.
    Liu F; Shi D; Jin R; Yu X
    Medicine (Baltimore); 2024 Sep; 103(37):e39603. PubMed ID: 39287269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-molecular-weight heparin and aspirin use in relation to pregnancy outcome in women with systemic lupus erythematosus and antiphospholipid syndrome: A cohort study.
    Abheiden CN; Blomjous BS; Kroese SJ; Bultink IE; Fritsch-Stork RD; Lely AT; de Boer MA; de Vries JI
    Hypertens Pregnancy; 2017 Feb; 36(1):8-15. PubMed ID: 27599157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low molecular weight heparin or LMWH plus aspirin in the treatment of unexplained recurrent miscarriage with negative antiphospholipid antibodies: A meta-analysis of randomized controlled trial.
    Yan X; Wang D; Yan P; Li H
    Eur J Obstet Gynecol Reprod Biol; 2022 Jan; 268():22-30. PubMed ID: 34794071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of anti-thrombotic therapy for recurrent pregnancy loss due to anti-phospholipid syndrome.
    Fawad S
    J Ayub Med Coll Abbottabad; 2010; 22(3):197-200. PubMed ID: 22338455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bleeding complications and antithrombotic treatment in 264 pregnancies in antiphospholipid syndrome.
    Yelnik CM; Lambert M; Drumez E; Le Guern V; Bacri JL; Guerra MM; Laskin CA; Branch DW; Sammaritano LR; Morel N; Guettrot-Imbert G; Launay D; Hachulla E; Hatron PY; Salmon JE; Costedoat-Chalumeau N
    Lupus; 2018 Sep; 27(10):1679-1686. PubMed ID: 30016929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial.
    Laskin CA; Spitzer KA; Clark CA; Crowther MR; Ginsberg JS; Hawker GA; Kingdom JC; Barrett J; Gent M
    J Rheumatol; 2009 Feb; 36(2):279-87. PubMed ID: 19208560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of therapeutic interventions for recurrent pregnancy loss in association with antiphospholipid syndrome: A systematic review and network meta-analysis.
    Liu X; Qiu Y; Yu ED; Xiang S; Meng R; Niu KF; Zhu H
    Am J Reprod Immunol; 2020 Apr; 83(4):e13219. PubMed ID: 31872490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin or aspirin or both in the treatment of recurrent abortions in women with antiphospholipid antibody (syndrome).
    Hoppe B; Burmester GR; Dörner T
    Curr Opin Rheumatol; 2011 May; 23(3):299-304. PubMed ID: 21346577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Refractory obstetrical antiphospholipid syndrome: Features, treatment and outcome in a European multicenter retrospective study.
    Mekinian A; Alijotas-Reig J; Carrat F; Costedoat-Chalumeau N; Ruffatti A; Lazzaroni MG; Tabacco S; Maina A; Masseau A; Morel N; Esteve-Valverde EE; Ferrer-Oliveras R; Andreoli L; De Carolis S; Josselin-Mahr L; Abisror N; Nicaise-Roland P; Tincani A; Fain O;
    Autoimmun Rev; 2017 Jul; 16(7):730-734. PubMed ID: 28478081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.